Document Detail


Genetic polymorphisms of N-acetyltransferases 1 and 2 and gene-gene interaction in the susceptibility to childhood acute lymphoblastic leukemia.
MedLine Citation:
PMID:  10868688     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer. In utero and postnatal exposures to various carcinogens may play a role in the etiology of this disease. N-acetyltransferases, encoded by the NAT1 and NAT2 genes are involved in the biotransformation of aromatic amines present in tobacco smoke, environment, and diet. Their rapid and slow acetylation activity alleles have been shown to modify the risk to a variety of solid tumors in adults. To investigate the role of NAT1 and NAT2 variants as risk-modifying factors in leukemogenesis, we conducted a case-control study on 176 ALL patients and 306 healthy controls of French-Canadian origin. Slow NAT2 acetylation genotype was found to be a significant risk determinant of ALL (odds ratio, 1.5; 95% confidence interval, 1.0-2.2) because of overrepresentation of the alleles NAT2*5C and *7B and underrepresentation of NAT2*4. Besides a slight increase in NAT1*4 allele frequency among cases, no independent association of NAT1 acetylation genotypes and ALL risk was observed. However, the risk associated with NAT2 slow acetylators was more apparent among homozygous individuals for NAT1*4 (odds ratio, 1.9; 95% confidence interval, 1.1-3.4). When NAT2 slow acetylators were considered together with the other risk-elevating genotypes, GSTM1 null and CYP1A1*2A, the risk of ALL increased further, which showed that the combination of these genotypes is more predictive of risk then either of them independently. These findings suggest that leukemogenesis in children is associated with carcinogen metabolism and consequently related to environmental exposures.
Authors:
M Krajinovic; C Richer; H Sinnett; D Labuda; D Sinnett
Related Documents :
22391688 - Fitness, fatness and survival in elderly populations.
21181218 - Gender and age impacts on the correlations between hyperuricemia and metabolic syndrome...
22564118 - Association between hla-drb1 polymorphisms and pemphigus vulgaris: a meta-analysis.
17640058 - Polymorphisms in ptgs1, ptgs2 and il-10 do not influence colorectal adenoma recurrence ...
18299498 - Incidence and prevalence of heart failure in elderly persons, 1994-2003.
17501998 - Corneal topographic changes in premenopausal and postmenopausal women.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology     Volume:  9     ISSN:  1055-9965     ISO Abbreviation:  Cancer Epidemiol. Biomarkers Prev.     Publication Date:  2000 Jun 
Date Detail:
Created Date:  2000-12-13     Completed Date:  2000-12-13     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9200608     Medline TA:  Cancer Epidemiol Biomarkers Prev     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  557-62     Citation Subset:  IM    
Affiliation:
Service d'Hématologie-Oncologie, Centre de Cancérologie Charles-Bruneau, Centre de Recherche, Hôpital Sainte-Justine, Montreal, Quebec, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetyltransferases / genetics*
Case-Control Studies
Child
Environmental Exposure
Female
Genetic Predisposition to Disease
Genotype
Humans
Male
Odds Ratio
Polymorphism, Genetic*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / enzymology*,  genetics*
Risk Factors
Chemical
Reg. No./Substance:
EC 2.3.1.-/Acetyltransferases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1...
Next Document:  Glutathione S-transferase polymorphisms in children with myeloid leukemia: a Children's Cancer Group...